603108.SH
润达医疗
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 9.55
−3.24%Year over year
Reported trailing growth
- Revenue
- -13.3%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -48.9%
- Operating cash flow
- -29.6%
Forward estimates
Based on analyst estimates
- Revenue
- -36.4%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -12.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -2.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026